Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions

References

• Olver J, Esquenazi A, Fung VSC, Singer BJ, Ward AB. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. Eur J Neurol. 2010;17(SUPPL. 2):57–73. doi:10.1111/ene.2010.17.issue-s2.
   PubMed Web of Science ®Google Scholar
• Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17(SUPPL. 2):74–93. doi:10.1111/ene.2010.17.issue-s2.
   PubMed Web of Science ®Google Scholar
• Moore EJ, Banky M, Olver J, Bryant AL, Williams G. The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: a systematic review. Brain Inj. 2015;29(6):676–87. doi:10.3109/02699052.2015.1004749.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Baguley IJ, Graaff S, Katrak P, Davies L, McCrory P, Hughes A. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med: Off J UEMS Eur Board Phys Rehabil Med. 2010;42:81–89. doi:10.2340/16501977-0474.
   Web of Science ®Google Scholar
• Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments: introduction. Eur J Neurol. 2010;17(SUPPL. 2):1–8. doi:10.1111/j.1468-1331.2010.03125.x.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Williams H, Johnson J. Goal attainment scaling: does it provide added value as a person-centred measure for evaluation of outcome in neurorehabilitation following acquired brain injury? J Rehabil Med. 2009;41(7):528–35. doi:10.2340/16501977-0383.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation. Pract Guide Clin Rehabil. 2009;23(4):362–70. doi:10.1177/0269215508101742.
   PubMed Web of Science ®Google Scholar
• Brashear A, Elovic E. Spasticity: diagnosis and management. New York: Demos Medical Publishing; 2010.
   Google Scholar
• Williams G, Olver J, De Graaff S, Singer BJ. The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals. Aust Occup Ther J. 2012;59(4):257–64. doi:10.1111/aot.2012.59.issue-4.
   PubMed Web of Science ®Google Scholar
• Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil. 2007;21(4):331–37. doi:10.1177/0269215507072772.
   PubMed Web of Science ®Google Scholar
• Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev: John Wiley Sons, Ltd. 2013. doi:10.1002/14651858.CD009689.pub2.
   Google Scholar
• Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair. 2010;24(1):34–41. doi:10.1177/1545968309341060.
   PubMed Web of Science ®Google Scholar
• Farina S, Migliorini C, Gandolfi M, Bertolasi L, Casarotto M, Manganotti P, Fiaschi A, Smania N. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Funct Neurol. 2008;23(2):87–91.
   PubMed Web of Science ®Google Scholar
• Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998;12(5):381–88. doi:10.1191/026921598668275996.
   PubMed Web of Science ®Google Scholar
• Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther. 2009;26(2):241–48. doi:10.1007/s12325-008-0139-2.
   PubMed Web of Science ®Google Scholar
• Kiresuk TJ, Sherman MRE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Commun Ment Health J. 1968;4(6):443–53. doi:10.1007/BF01530764.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P, Zakine B. Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice. Br Med J Open. 2013;3(3):e002230.
   PubMed Web of Science ®Google Scholar
• Keith RA. Treatment strength in rehabilitation. Arch Phys Med Rehabil. 1997;78(12):1298–304. doi:10.1016/S0003-9993(97)90300-2.
   PubMed Web of Science ®Google Scholar
• Cumming G. Understanding the new statistics: effect sizes, confidence intervals, and meta-analysis. New York: Routledge; 2012.
   Google Scholar
• Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P. Results from the Upper Limb International Spasticity Study-II (ULIS-II): A large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management. Br Med J Open. 2013;3:6.
   Web of Science ®Google Scholar
• Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. John Hoboken, New Jersey: John Wiley & Sons; 2013.
   Google Scholar
• Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74(368):829–36. doi:10.1080/01621459.1979.10481038.
   Web of Science ®Google Scholar
• Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, California: Wadsworth; 1984.
   Google Scholar
• Nguyen S, McKenzie D, McKay A, Wong D, Rajaratnam SMW, Spitz G, Williams G, Mansfield D, Ponsford J. Exploring predictors of treatment outcome in cognitive behavior therapy for sleep disturbance following acquired brain injury. Disabil Rehabil. in press. 2017;19:1–8.
   Google Scholar
• McKenzie DP, Sim MR, Clarke DM, Forbes AB, Ikin JF, Kelsall HL. Developing a brief depression screen and identifying associations with comorbid physical and psychosocial ilnness in Australian Gulf War veterans. J Psychosom Res. 2015;79(6):566–73. doi:10.1016/j.jpsychores.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Davis AS, Finch WH, Trinkle JM, Dean RS, Woodcock RW. Classification and regression tree analysis of a neurologically impaired and normal sample using sensory-marker tasks. Int J Neurosci. 2008;117(1):11–23. doi:10.1080/00207450500535453.
   Web of Science ®Google Scholar
• Mills PB, Finlayson H, Sudol M, O’Connor R. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity. Clin Rehabil. 2016;30(6):537–48. doi:10.1177/0269215515593783.
   PubMed Web of Science ®Google Scholar
• Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke. J Rehabil Med. 2014;46(8):730–737p. doi:10.2340/16501977-1842.
   PubMed Web of Science ®Google Scholar
• Campanini I, Merlo A, Damiano B. A method to differentiate the causes of stiff-knee gait in stroke patients. Gait Posture. 2013;38(2):165–69. doi:10.1016/j.gaitpost.2013.05.003.
   PubMed Web of Science ®Google Scholar
• Badjatia N, Carpenter A, Fernandez L, Schmidt JM, Mayer SA, Claassen J, Lee K, Connolly ES, Seres D, Elkind MS. Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (00392499). 2011;42(9):2436–42. doi:10.1161/STROKEAHA.111.614685.
   PubMed Web of Science ®Google Scholar
• Muratori LM, Lamberg EM, Quinn L, Duff SV. Applying principles of motor learning and control to upper extremity rehabilitation. J Hand Ther: Off J Am Soc Hand Therapists. 2013;26(2):94–103. doi:10.1016/j.jht.2012.12.007.
   PubMed Web of Science ®Google Scholar
• Nott MT, Barden HLH, Baguley IJ. Goal attainment following upper-limb botulinum toxin-a injections: are we facilitating achievement of client-centred goals? J Rehabil Med. 2014;46(9):864–8685p. doi:10.2340/16501977-1853.
   PubMed Web of Science ®Google Scholar
• Ashford S, Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiother Res Int. 2006;11(1):24–34. doi:10.1002/(ISSN)1471-2865.
   PubMedGoogle Scholar
• McCrory P, Turner-Stokes L, Baguley IJ, Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med. 2009;41:536–44. doi:10.2340/16501977-0366.
   PubMed Web of Science ®Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry. 2000;217–21. doi:10.1136/jnnp.69.2.217.
   PubMed Web of Science ®Google Scholar
• Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347:395–400. doi:10.1056/NEJMoa011892.
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F. Ward CD and others. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke. 2000;31:2402–06. doi:10.1161/01.STR.31.10.2402.
   PubMed Web of Science ®Google Scholar
• Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity. Disabil Rehabil. 2015;38(19):1927–33.
   PubMed Web of Science ®Google Scholar
• Ward AB, Wissel J, Borg J, Ertzgaard P, Herrmann C, Kulkarni J, Lindgren K, Reuter I, Sakel M, Säterö P, et al. Functional goal achievement in post-stroke spasticity patients: the Botox economic spasticity trial (Best). J Rehabil Med. 2014;46(6):504–51310p. doi:10.2340/16501977-1817.
   PubMed Web of Science ®Google Scholar
• Stolee P, Stadnyk K, Myers AM, Rockwood K. An individualized approach to outcome measurement in geriatric rehabilitation. J Gerontol Ser A: Biol Sci Med Sci. 1999;54(12):M641–M647. doi:10.1093/gerona/54.12.M641.
   PubMed Web of Science ®Google Scholar
• Stolee P, Zaza C, Pedlar A, Myers AM. Clinical experience with goal attainment scaling in geriatric care. J Aging Health. 1999;11(1):96–124. doi:10.1177/089826439901100106.
   PubMed Web of Science ®Google Scholar
• Zaza C, Stolee P, Prkachin K. The application of goal attainment scaling in chronic pain settings. J Pain Symptom Manage. 1999;17(1):55–64. doi:10.1016/S0885-3924(98)00106-7.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Joyce B, Stolee P. Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. J Clin Epidemiol. 1997;50(5):581–88. doi:10.1016/S0895-4356(97)00014-0.
   PubMed Web of Science ®Google Scholar